Efficacy and safety of cariprazine in bipolar I depression: A double‐blind, placebo‐controlled phase 3 study

Documenti analoghi

• Evaluation of cariprazine in the treatment of bipolar I and II depression: a randomized, double-blind, placebo-controlled, phase 2 trial
  di: Yatham, Lakshmi N., et al.
  Pubblicazione: (2020)
• Cariprazine efficacy in bipolar I depression with and without concurrent manic symptoms: post hoc analysis of 3 randomized, placebo-controlled studies
  di: McIntyre, Roger S., et al.
  Pubblicazione: (2020)
• Efficacy of cariprazine in bipolar I depression across patient characteristics: a post hoc analysis of pooled randomized, placebo-controlled studies
  di: Patel, Mehul, et al.
  Pubblicazione: (2020)
• Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial
  di: Earley, Willie R., et al.
  Pubblicazione: (2018)
• Efficacy of adjunctive low-dose cariprazine in major depressive disorder: a randomized, double-blind, placebo-controlled trial
  di: Fava, Maurizio, et al.
  Pubblicazione: (2018)